Front Row Advisors LLC Buys New Position in Medidata Solutions Inc (MDSO)

Front Row Advisors LLC bought a new stake in Medidata Solutions Inc (NASDAQ:MDSO) during the fourth quarter, HoldingsChannel.com reports. The firm bought 10,973 shares of the company’s stock, valued at approximately $695,000.

Other hedge funds also recently bought and sold shares of the company. AMP Capital Investors Ltd bought a new stake in Medidata Solutions in the third quarter valued at $2,194,000. Zions Bancorporation bought a new stake in Medidata Solutions in the third quarter valued at $256,000. Schwab Charles Investment Management Inc. lifted its stake in Medidata Solutions by 38.3% in the third quarter. Schwab Charles Investment Management Inc. now owns 326,950 shares of the company’s stock valued at $25,522,000 after buying an additional 90,572 shares during the last quarter. Summit Creek Advisors LLC bought a new stake in Medidata Solutions in the fourth quarter valued at $5,137,000. Finally, KAMES CAPITAL plc lifted its stake in Medidata Solutions by 54.6% in the fourth quarter. KAMES CAPITAL plc now owns 25,521 shares of the company’s stock valued at $1,617,000 after buying an additional 9,012 shares during the last quarter. Institutional investors own 97.52% of the company’s stock.

In related news, Director Robert Taylor sold 5,000 shares of Medidata Solutions stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $71.39, for a total transaction of $356,950.00. Following the transaction, the director now directly owns 49,372 shares of the company’s stock, valued at $3,524,667.08. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Rouven Bergmann sold 3,000 shares of Medidata Solutions stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of $70.00, for a total value of $210,000.00. Following the transaction, the chief financial officer now directly owns 84,775 shares in the company, valued at $5,934,250. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 34,010 shares of company stock worth $2,319,156. 5.80% of the stock is owned by corporate insiders.

MDSO has been the topic of a number of recent research reports. Wells Fargo & Co cut their target price on Medidata Solutions from $83.00 to $80.00 and set a “market perform” rating on the stock in a research note on Friday, October 27th. SunTrust Banks reiterated a “buy” rating and issued a $92.00 target price on shares of Medidata Solutions in a research note on Friday, October 27th. Royal Bank of Canada reiterated a “hold” rating and issued a $80.00 target price on shares of Medidata Solutions in a research note on Friday, October 27th. Zacks Investment Research cut shares of Medidata Solutions from a “hold” rating to a “sell” rating in a research note on Thursday, November 2nd. Finally, Dougherty & Co initiated coverage on shares of Medidata Solutions in a research note on Thursday, November 2nd. They set a “neutral” rating on the stock. One research analyst has rated the stock with a sell rating, three have given a hold rating and eleven have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $84.54.

Medidata Solutions Inc (NASDAQ:MDSO) traded down $0.51 during trading hours on Thursday, reaching $67.60. The company had a trading volume of 36,720 shares, compared to its average volume of 471,063. The firm has a market capitalization of $3,960.00, a price-to-earnings ratio of 96.76, a P/E/G ratio of 3.58 and a beta of 1.69. Medidata Solutions Inc has a 1 year low of $47.77 and a 1 year high of $85.92. The company has a current ratio of 1.29, a quick ratio of 3.37 and a debt-to-equity ratio of 0.61.

TRADEMARK VIOLATION NOTICE: This news story was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this news story on another domain, it was stolen and republished in violation of international copyright and trademark laws. The original version of this news story can be read at https://www.com-unik.info/2018/02/01/front-row-advisors-llc-buys-new-position-in-medidata-solutions-inc-mdso.html.

Medidata Solutions Company Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions Inc (NASDAQ:MDSO).

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit